Liubing Du

Bio Island
Guangzhou, 510320, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

SARS-CoV-2 3CLpro inhibits the replication of influenza viruses through the cleavage of NP and PA.

SARS-CoV-2 3CLpro inhibits the replication of influenza viruses through the cleavage of NP and PA.

Journal: Virologica Sinica

Published: April 01, 2026

The transmembrane segments of SARS-CoV-2 nsp3 govern viral intracellular trafficking.

The transmembrane segments of SARS-CoV-2 nsp3 govern viral intracellular trafficking.

Journal: Cell & bioscience

Published: January 19, 2026

PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3β-N-nsp3 cascade.

PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3β-N-nsp3 cascade.

Journal: Journal of medical virology

Published: March 16, 2023

ORF8 protein of SARS-CoV-2 reduces male fertility in mice.

ORF8 protein of SARS-CoV-2 reduces male fertility in mice.

Journal: Journal of medical virology

Published: April 27, 2022

Inhibition of SARS-CoV-2 replication by zinc gluconate in combination with hinokitiol.

Inhibition of SARS-CoV-2 replication by zinc gluconate in combination with hinokitiol.

Journal: Journal of inorganic biochemistry

Published: January 19, 2022

Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication.

Oxidative stress transforms 3CLpro into an insoluble and more active form to promote SARS-CoV-2 replication.

Journal: Redox biology

Published: November 06, 2021

Allosteric inhibition of SARS-CoV-2 3CL protease by colloidal bismuth subcitrate.

Allosteric inhibition of SARS-CoV-2 3CL protease by colloidal bismuth subcitrate.

Journal: Chemical science

Published: June 28, 2021

Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.

Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication.

Journal: Cell & bioscience

Published: March 17, 2021

A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery.

A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery.

Journal: Virologica Sinica

Published: March 02, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026